Isolation, characterization, and differential expression of the murine Sox-2 promoter

Gene

Volumn 246, Issue 1-2, 2000, Pages 383-393

  Wiebe, Matthew S ^a,b   Wilder, Philip J ^a   Kelly, David ^a   Rizzino, Angie ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Embryonal carcinoma cells; FGF 4; NF Y; SRY; UTF1

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA FLANKING REGION; DNA SEQUENCE; EMBRYONAL CARCINOMA; GENE CONTROL; GENE EXPRESSION; GENE ISOLATION; GENE SEQUENCE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FAMILY; SITE DIRECTED MUTAGENESIS; SOUTHERN BLOTTING;

ANIMALS; BASE SEQUENCE; BINDING SITES; CCAAT-ENHANCER-BINDING PROTEINS; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DNA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HMGB PROTEINS; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

MURINAE;

EID: 0034603811     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(00)00086-X     Document Type: Article

References (32)

1. Botquin V., Hess H., Fuhrmann G., Anastassiadis C., Gross M.K., Vriend G., Scholer H.R. New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Genes Dev. 12:1998;2073-2090.
2. Boucher P.D., Piechocki M.P., Hines R.N. Partial characterization of the human CYP1A1 negatively acting transcription factor and mutational analysis of its cognate DNA recognition sequence. Mol. Cell Biol. 15:1995;5144-5151.
3. Boucher P.D., Ruch R.J., Hines R.N. Specific nuclear protein binding to a negative regulatory element on the human CYP1A1 gene. J. Biol. Chem. 268:1993;17384-17391.
4. Bucher P. Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J. Mol. Biol. 212:1990;563-578.
5. Collignon J., Sockanathan S., Hacker A., Cohen-Tannoudji M., Norris D., Rastan S., Stevanovic M., Goodfellow P.N., Lovell-Badge R. A comparison of the properties of Sox-3 with Sry and two related genes, Sox-1 and Sox-2. Development. 122:1996;509-520.
6. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
7. Fried M., Crothers D.M. Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res. 9:1981;6505-6525.
8. Johnson L.R., Lamb K.A., Gao Q., Nowling T.K., Rizzino A. Role of the transcription factor Sox-2 in the expression of the FGF-4 gene in embryonal carcinoma cells. Mol. Reprod. Dev. 50:1998;377-386.
9. Kamachi Y., Sockanathan S., Liu Q., Breitman M., Lovell-Badge R., Kondoh H. Involvement of SOX proteins in lens-specific activation of crystallin genes. EMBO J. 14:1995;3510-3519.
10. Kelly D., Kim S.J., Rizzino A. Transcriptional activation of the type II transforming growth factor-beta receptor gene upon differentiation of embryonal carcinoma cells. J. Biol. Chem. 273:1998;21115-21124.
11. Kelly D., Scholtz B., Orten D.J., Hinrichs S.H., Rizzino A. Regulation of the transforming growth factor-beta 2 gene promoter in embryonal carcinoma cells and their differentiated cells: differential utilization of transcription factors. Mol. Reprod. Dev. 40:1995;135-145.
12. Kuhlbrodt K., Herbarth B., Sock E., Enderich J., Hermans-Borgmeyer I., Wegner M. Cooperative function of POU proteins and SOX proteins in glial cells. J. Biol. Chem. 273:1998;16050-16057.
13. Kuhlbrodt K., Herbarth B., Sock E., Hermans-Borgmeyer I., Wegner M. Sox10, a novel transcriptional modulator in glial cells. J. Neurosci. 18:1998;237-250.
14. Lamb K.A., Johnson L.R., Rizzino A. NF-Y binds to the CCAAT box motif of the FGF-4 gene and promotes FGF-4 expression in embryonal carcinoma cells. Mol. Reprod. Dev. 48:1997;301-309.
15. Ma Y.G., Rosfjord E., Huebert C., Wilder P., Tiesman J., Kelly D., Rizzino A. Transcriptional regulation of the murine k-FGF gene in embryonic cell lines. Dev. Biol. 154:1992;45-54.
16. Mantovani R. A survey of 178 NF-Y binding CCAAT boxes. Nucleic Acids Res. 26:1998;1135-1143.
17. Nishimoto M., Fukushima A., Okuda A., Muramatsu M. The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2. Mol. Cell Biol. 19:1999;5453-5465.
18. Nowling T., Johnson L.R., Wiebe M., Rizzino A. Identification of the transactivation domain of the transcription factor Sox-2 and an associated co-activator. J. Biol. Chem. 275:2000;3810-3818.
19. Okamoto K., Okazawa H., Okuda A., Sakai M., Muramatsu M., Hamada H. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell. 60:1990;461-472.
20. Payen E., Pailhoux E., Gianquinto L., Hayes H., Le Pennec N., Bezard J., Cotinot C. The ovine SOX2 gene: sequence, chromosomal localization and gonadal expression. Gene. 189:1997;143-147.
21. Pevny L.H., Sockanathan S., Placzek M., Lovell-Badge R. A role for SOX1 in neural determination. Development. 125:1998;1967-1978.
22. Piechocki M.P., Hines R.N. Functional characterization of the human CYP1A1 negative regulatory element: modulation of Ah receptor mediated transcriptional activity. Carcinogenesis. 19:1998;771-780.
23. Razin A. CpG methylation, chromatin structure and gene silencing-a three-way connection. EMBO J. 17:1998;4905-4908.
24. Rizzino A. Use of embryonal carcinoma cells to study growth factors during early mammalian development. Rosenblum L.Y., Heyner S. Growth Factors in Mammalian Development. 1989;113-134 CRC Press, Boca Raton.
25. Rosfjord E., Lamb K., Rizzino A. Cryptic promoter activity within the backbone of a plasmid commonly used to prepare promoter/reporter gene constructs. In Vitro Cell Dev. Biol. Anim. 30A:1994;477-481.
26. Scholtz B., Lamb K., Rosfjord E., Kingsley M., Rizzino A. Appearance of nuclear protease activity after embryonal carcinoma cells undergo differentiation. Dev. Biol. 173:1996;420-427.
27. Strickland S., Mahdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell. 15:1978;393-403.
28. van de Wetering M., Oosterwegel M., van Norren K., Clevers H. Sox-4, an Sry-like HMG box protein, is a transcriptional activator in lymphocytes. EMBO J. 12:1993;3847-3854.
29. Wasylyk B., Hahn S.L., Giovane A. The Ets family of transcription factors. Eur. J. Biochem. 211:1993;7-18.
30. Wegner M. From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res. 27:1999;1409-1420.
31. Xin J.H., Cowie A., Lachance P., Hassell J.A. Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells. Genes Dev. 6:1992;481-496.
32. Yuan H., Corbi N., Basilico C., Dailey L. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 9:1995;2635-2645.